Literature DB >> 12592562

Protective immunity in human lymphatic filariasis: problems and prospects.

Balachandran Ravindran1, Ashok K Satapathy, Prakash K Sahoo, Madhu Chhanda Mohanty.   

Abstract

Human filariasis caused by lymphatic dwelling nematodes, affecting 120 million persons worldwide, is a major public health problem. Efforts towards development of vaccines for such large tissue-dwelling nematodes depends significantly on identification and demonstration of protective immunity in the exposed population. Immunological studies conducted in human filariasis so far are essentially attempts to establish a correlation of the immune response phenotypes with presence or absence of filarial infections/disease in the host, and the cause-effect relationship between the observed immune responses in the host and protective immunity continues to be conjectural. This short review attempts to clarify the functional definition of protective immunity, problems associated with identification of putatively immune subjects in endemic areas, role of antibodies reactive to surface of microfilariae and larvae stages of filarial parasites and importance of undertaking immunological investigations on a longitudinal basis in different cohorts of subjects presenting with one or the features of infection and/or disease for more accurate delineation of protective immunity in human filariasis.

Entities:  

Mesh:

Year:  2002        PMID: 12592562     DOI: 10.1007/s00430-002-0157-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  8 in total

1.  Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis.

Authors:  Natarajan Mahalakshmi; Ramanathan Aparnaa; Lawrance Ansel Vishal; Perumal Kaliraj
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

2.  Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.

Authors:  Christiana Immanuel; Aparnaa Ramanathan; Malathi Balasubramaniyan; Vishal Kishor Khatri; Nitin Purushottam Amdare; Donthamsetty Nageswara Rao; Maryada Venkata Rami Reddy; Kaliraj Perumal
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

3.  High Tregs and systemic IL-10 expressions linked to the absence of sheath antibodies in lymphatic filariasis: implications on the persistence of residual infection.

Authors:  Madhusmita Bal; Manoranjan Ranjit; Hemanta K Khuntia; Ashok K Satapathy; K Gopinath Achary; Bhagirathi Dwibedi; Sanghamitra Pati
Journal:  Immunol Res       Date:  2021-01-30       Impact factor: 2.829

4.  Caspase dependent programmed cell death in developing embryos: a potential target for therapeutic intervention against pathogenic nematodes.

Authors:  Alok Das Mohapatra; Sunil Kumar; Ashok Kumar Satapathy; Balachandran Ravindran
Journal:  PLoS Negl Trop Dis       Date:  2011-09-13

5.  A flow cytometry based method for studying embryogenesis and immune reactivity to embryogenic stages in filarial parasites.

Authors:  Bikash Ranjan Sahu; Alok Das Mohapatra; Arindam Majumder; Pradip K Das; Balachandran Ravindran
Journal:  Filaria J       Date:  2005-11-07

Review 6.  Promising Technologies in the Field of Helminth Vaccines.

Authors:  Dilhan J Perera; Momar Ndao
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

7.  Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Gnanasekar Munirathinam; Kristen Stoicescu; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

Review 8.  Killing filarial nematode parasites: role of treatment options and host immune response.

Authors:  Alexander Kwarteng; Samuel Terkper Ahuno; Freda Osei Akoto
Journal:  Infect Dis Poverty       Date:  2016-10-03       Impact factor: 4.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.